Participation of Clinical Pharmacists in One Case of Late-onset Infection after Artificial Hip Joints Replace-ment
- VernacularTitle:临床药师参与治疗人工髋关节置换术后迟发性感染1例
- Author:
Peitao XIE
1
Author Information
1. 鄂尔多斯市中心医院药剂科 内蒙古鄂尔多斯017000
- Keywords:
Artificial hip joint infection;
Staphylococcus aureus;
Rifampicin;
Cefazolin
- From:
China Pharmacist
2018;21(2):302-305
- CountryChina
- Language:Chinese
-
Abstract:
In order to explore the value of clinical pharmacist in the anti-infective treatment of the patients with late-onset infec-tion after artificial hip joints replacement,clinical pharmacists performed ward round and pharmaceutical care for one patient with infec-tion around the artificial joints after artificial hip joints replacement three years ago. According to the relevant literatures,clinical phar-macist provided medical advice for physician from the following aspects: surgical interventions, drug choice and dosage adjustment, and participated in the medicine therapeutic scheme for the patient. Physicians partly accepted the suggestions of clinical pharmacists, and the symptoms and imaging examination results of the patient improved after the treatment,which provided guarantee for the follow-up treatment. It is of great significance for clinical pharmacists to participate in the formulation of clinical medication plan to improve the rational drug use in clinical anti-infection treatment.
